Earnings$SNN6:09 AM ET

Smith & Nephew guidance cut signals weak Q4 organic growth

By BORSA NewsroomPublished Nov 4, 2026, 6:09 AM ESTUpdated Nov 4, 2026, 6:10 AM EST

UBS says Smith & Nephew's guidance cut implies a 2% cut to 2026 consensus trading profit and very weak Q4 organic growth of 2.3% after adjusting for trading days. Strategic options for orthopedics unit not imminent. Shares down 0.45%.

Sentimentbearish 25

Bearish · 25 of 100

Impact60

medium · sector-wide

Confidence90%

high confidence · single wire

Eventdeveloping

v1 · alerted to followers

WHAT WE KNOW

Smith & Nephew Q3 update missed expectations.
Guidance cut implies 2% reduction to 2026 consensus trading profit.